These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 15565569

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Primary sclerosing cholangitis and bile acids.
    Chazouillères O.
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S21-5. PubMed ID: 23141889
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
    Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A.
    Hepatology; 1996 Jun; 23(6):1484-90. PubMed ID: 8675168
    [Abstract] [Full Text] [Related]

  • 27. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome.
    Floreani A, Rizzotto ER, Ferrara F, Carderi I, Caroli D, Blasone L, Baldo V.
    Am J Gastroenterol; 2005 Jul; 100(7):1516-22. PubMed ID: 15984974
    [Abstract] [Full Text] [Related]

  • 28. A retrospective single-center review of primary sclerosing cholangitis in children.
    Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N.
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial.
    Rautiainen H, Kärkkäinen P, Karvonen AL, Nurmi H, Pikkarainen P, Nuutinen H, Färkkilä M.
    Hepatology; 2005 Apr; 41(4):747-52. PubMed ID: 15754377
    [Abstract] [Full Text] [Related]

  • 32. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.
    Sinakos E, Marschall HU, Kowdley KV, Befeler A, Keach J, Lindor K.
    Hepatology; 2010 Jul; 52(1):197-203. PubMed ID: 20564380
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.
    Imam MH, Sinakos E, Gossard AA, Kowdley KV, Luketic VA, Edwyn Harrison M, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, DeCook AC, Enders F, Lindor KD.
    Aliment Pharmacol Ther; 2011 Nov; 34(10):1185-92. PubMed ID: 21957881
    [Abstract] [Full Text] [Related]

  • 35. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Lindor KD.
    Am J Gastroenterol; 2011 Sep; 106(9):1638-45. PubMed ID: 21556038
    [Abstract] [Full Text] [Related]

  • 36. Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.
    Arat M, Idilman R, Soydan EA, Soykan I, Erden E, Karayalçin S, Akan H.
    Clin Transplant; 2005 Dec; 19(6):798-803. PubMed ID: 16313328
    [Abstract] [Full Text] [Related]

  • 37. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
    van de Meeberg PC, Wolfhagen FH, Van Berge-Henegouwen GP, Salemans JM, Tangerman A, van Buuren HR, van Hattum J, van Erpecum KJ.
    J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
    [Abstract] [Full Text] [Related]

  • 38. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Löfberg R.
    Anticancer Res; 2004 Dec; 24(5B):3121-7. PubMed ID: 15510599
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?
    Angulo P, Jorgensen RA, Lindor KD.
    Am J Gastroenterol; 2001 Nov; 96(11):3152-7. PubMed ID: 11721764
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.